BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19348379)

  • 21. [Wilms' tumor in adults].
    Kälble T; Staehler G; Richter GM; Waldherr R
    Urologe A; 1990 Jul; 29(4):215-8. PubMed ID: 2169084
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Derivation and characterization of a Wilms' tumour cell line, WiT 49.
    Alami J; Williams BR; Yeger H
    Int J Cancer; 2003 Nov; 107(3):365-74. PubMed ID: 14506735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Expression of Stat3, HIF-1alpha and VEGF in Wilms' tumor].
    Niu ZB; Wang CL; Hou Y; Yang Y; Gao H
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Oct; 9(5):461-4. PubMed ID: 17937859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of lung resistance-related protein in transitional cell carcinoma of bladder.
    Zhu Y; Kong C; Zeng Y; Sun Z; Gao H
    Urology; 2004 Apr; 63(4):694-8. PubMed ID: 15072883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nephroblastomas (Wilms' tumors) and special variations of nephroblastomas].
    Schmidt D
    Veroff Pathol; 1989; 133():1-174. PubMed ID: 2556868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephroblastoma: multidrug-resistance P-glycoprotein expression in tumor cells and intratumoral capillary endothelial cells.
    Camassei FD; Arancia G; Cianfriglia M; Bosman C; Francalanci P; Ravà L; Jenkner A; Donfrancesco A; Boldrini R
    Am J Clin Pathol; 2002 Mar; 117(3):484-90. PubMed ID: 11888090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Results of Wilms' tumour management in two tertiary-care hospitals in Asia.
    Sen S; Kadamba P; Al-AbdulAaly M; Mammen KE; Ahmed S
    Pediatr Surg Int; 1998 Jan; 13(1):42-4. PubMed ID: 9391203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic relevance of preoperative transcatheter arterial chemoembolization (TACE) and PCNA/VEGF expression in patients with Wilms' tumour.
    Liu WG; Gu WZ; Zhou YB; Tang HF; Li MJ; Ma WX
    Eur J Clin Invest; 2008 Dec; 38(12):931-8. PubMed ID: 19021718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Nephroblastomatosis and its relation to Wilms' tumor].
    Kodet R
    Cesk Patol; 1990 May; 26(2):72-9. PubMed ID: 2164453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of E-cadherin, cadherin-11, alpha-, beta- and gamma-catenins in nephroblastomas: relationship with clinicopathological parameters, prognostic factors and outcome.
    Ramburan A; Hadley GP; Govender D
    Pathology; 2006 Feb; 38(1):39-44. PubMed ID: 16484007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk stratification and consecutive prognosis progresses in childhood Wilms tumors. Two cases report.
    Diaconescu S; Olaru C; Mihailă D; Aprodu SG; Miron I
    Chirurgia (Bucur); 2013; 108(1):106-11. PubMed ID: 23464780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-kit protein expression in Wilms' tumour: an immunohistochemical study.
    Giordano G; Campanini N; Rocco A; Donofrio V; Bertolini P; Falleti J; Pettinato G
    Eur J Surg Oncol; 2009 Jun; 35(6):629-35. PubMed ID: 19010635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of apoptosis, cell proliferation, and drug resistance genes in pediatric Wilms' tumors.
    Ramachandran C; Melnick SJ; Escalon E; Jhabvala P; Khatib Z; Alamo A; Smith S
    Anticancer Res; 2000; 20(5C):3759-65. PubMed ID: 11268451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours.
    Lemoine NR; Hughes CM; Cowell JK
    J Pathol; 1992 Oct; 168(2):237-42. PubMed ID: 1334142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters.
    Rybárová S; Hodorová I; Hajduková M; Schmidtová K; Mojzis J; Kajo K; Kviatkovská Z; Plank L; Benický M; Mirossay A; Biros E; Bobrov N; Wagnerová M; Berc A; Mirossay L
    Neoplasma; 2006; 53(2):128-35. PubMed ID: 16575468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Wilms' tumor: past, present and (possibly) future.
    Spreafico F; Bellani FF
    Expert Rev Anticancer Ther; 2006 Feb; 6(2):249-58. PubMed ID: 16445377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression of the heat shock protein 70 in the histological compartments of nephroblastomas.
    Efferth T; Schulten HG; Thelen P; Bode ME; Beniers AJ; Granzen B; Ringert RH; Mertens R; Gefeller O; Jakse G; Fuzesi L
    Anticancer Res; 2001; 21(4B):2915-20. PubMed ID: 11712786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. S100 protein expression distinguishes metanephric adenomas from other renal neoplasms.
    Azabdaftari G; Alroy J; Banner BF; Ucci A; Bhan I; Cheville JC
    Pathol Res Pract; 2008; 204(10):719-23. PubMed ID: 18621486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.